| Excerpt | Relevance | Reference |
|---|
| "It is necessary to conduct a meta-analysis of the clinical randomized controlled trials (RCTs) on ropinirole in the treatment of Parkinson disease (PD), to explore the effects and safety of ropinirole, and to provide a theoretical basis for clinically safe and rational drug use." | 9.12 | The effect and safety of ropinirole in the treatment of Parkinson disease: A systematic review and meta-analysis. ( Chen, M; Zhu, J, 2021) |
| "To assess the efficacy, safety, and tolerability of ropinirole in the treatment of patients with restless legs syndrome." | 9.11 | Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. ( de Weerd, AW; Ferini-Strambi, L; Garcia-Borreguero, D; Lainey, E; Montagna, P; Saletu-Zyhlarz, G; Telstad, W; Tidswell, P; Trenkwalder, C, 2004) |
| "It is necessary to conduct a meta-analysis of the clinical randomized controlled trials (RCTs) on ropinirole in the treatment of Parkinson disease (PD), to explore the effects and safety of ropinirole, and to provide a theoretical basis for clinically safe and rational drug use." | 5.12 | The effect and safety of ropinirole in the treatment of Parkinson disease: A systematic review and meta-analysis. ( Chen, M; Zhu, J, 2021) |
| "To assess the efficacy, safety, and tolerability of ropinirole in the treatment of patients with restless legs syndrome." | 5.11 | Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. ( de Weerd, AW; Ferini-Strambi, L; Garcia-Borreguero, D; Lainey, E; Montagna, P; Saletu-Zyhlarz, G; Telstad, W; Tidswell, P; Trenkwalder, C, 2004) |